At 3 years, the LAAO’s Amulet remains inferior in safety and efficacy to the Watchman

September 17, 2022

2 minutes to learn

Supply / Disclosures


Lakeredde D et al. Late Science in Structural Cardiology: Session Two, in Collaboration with European Coronary heart Journal / Eurointervention. Offered at: TCT Scientific Symposium; 16-19 September 2022; Boston (blended assembly).

Lakereddy reported receiving a advisor price or speaker price/price from Abbott Vascular, BIOTRONIK, Janssen & Johnson & Johnson.

We have been unable to course of your request. Please strive once more later. If this problem nonetheless happens, please contact

BOSTON – At 3 years, the Amplatzer Amulet has remained superior to left atrial appendage obstruction and inferior in security and efficacy in comparison with the Watchman, researchers report at TCT 2022.

The Amulet IDE large-scale randomized trial in contrast two left atrial obstruction (LAAO) gadgets, Amulet (Abbott) and Watchman 2.5 (Boston Scientific), in sufferers with non-valvular atrial fibrillation requiring stroke prevention.

heart with gears
Supply: Adobe Inventory

“The take-home message to most of the people is to belief the closure of the amulet to offer quick and long-term closure in order that sufferers can safely take away oral anticoagulant medicines from their every day lives,” Dhanunjaya Lakkireddy, MD, medical electrophysiologist and medical director of the Kansas Metropolis Coronary heart Rhythm Institute at HCA Midwest Well being, throughout a press convention. “It enhances the preliminary outcomes and our data of those gadgets.”

In keeping with an organization press launch issued when the system acquired FDA approval in August 2021, the mascot options on the spot LAAO “double-sealing know-how,” decreasing the chance of stroke and eliminating the necessity for oral anticoagulation. Watchman 2.5 makes use of a single sealing seal.

For the Amulet IDE trial, researchers randomly assigned 1,878 sufferers with non-valvular atrial fibrillation in danger for LAAO stroke utilizing both Amulet or Watchman gadgets (imply age, 75 years; 60% males).

As beforehand reported by Healio, the Amulet was superior to the LAAO and never inferior in security and efficacy at 18 months in comparison with the Watchman 2.5.

For the present evaluation, researchers evaluated the efficacy and security of a 3-year amulet in comparison with a Watchman. Outcomes of curiosity included a composite of stroke, systemic embolism, or CV loss of life. loss of life from all causes and loss of life from autobiography; Important and sophisticated bleeding from stroke or systemic embolism.

Extra sufferers within the Amulet group accomplished a 3-year follow-up than the Watchman group (92% versus 86.7%) as a result of extra deaths and withdrawals within the Watchman group by 18 months, Lakeriddy stated on the press convention.

At 3 years, extra sufferers within the Watchman arm have been taking oral anticoagulants for thrombosis related to the system than within the mascot group (3.7% vs 7.3%; s <.01) in keeping with the research.

The researchers reported a development towards decrease CV and all-cause mortality amongst individuals assigned to the amulet in comparison with Watchman 2.5.

The charges of systemic stroke/embolism (mascot, 5%; observer, 4.6%) and main bleeding (mascot, 16.1%; observer 14.7%) have been related between the 2 teams (s > .05 for each).

Moreover, device-related elements corresponding to thrombosis or leakage across the system extra typically preceded stroke after LAAO with Watchman than with Amulet (17 sufferers vs 4 sufferers) after 6 months.

Dhanunjaya Lakkireddy

“The outcomes have been comparable for 3 years,” Lakereddy stated in the course of the presentation. “There was a slight development towards a better fee of CV loss of life and all-cause loss of life within the Watchman arm…mixed systemic stroke/embolism; main bleeding outcomes weren’t considerably totally different between these two teams.”

Lakeriddy famous in the course of the press convention that because the Amulet IDE research, a brand new era of the Watchman-FLX has entered the market.